Back to Search
Start Over
A phase II, two-stage study of avelumab and axitinib among patients with mismatch repair proficient recurrent or persistent endometrial cancer: Final efficacy analysis and correlative studies.
- Source :
-
Gynecologic Oncology . 2024 Supplement 1, Vol. 190, pS283-S284. 2p. - Publication Year :
- 2024
- Subjects :
- *ENDOMETRIAL cancer
Subjects
Details
- Language :
- English
- ISSN :
- 00908258
- Volume :
- 190
- Database :
- Academic Search Index
- Journal :
- Gynecologic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 180154333
- Full Text :
- https://doi.org/10.1016/j.ygyno.2024.07.421